Multifaceted role of sialylation in prion diseases

Frontiers in Neuroscience

Volumn 10, Issue AUG, 2016, Pages

  Baskakov, Ilia V ^a   Katorcha, Elizaveta ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Amyloid; Neuraminidase; Prion disease; Prions; Sialic acid; Sialylation; Sialyltransferase; Species barrier

Indexed keywords

GLYCAN; PRION PROTEIN; SIALIDASE; SIALYLTRANSFERASE;

BRAIN METABOLISM; HUMAN; NEUROTOXICITY; NONHUMAN; OUTCOME ASSESSMENT; PRION; PRION DISEASE; PROTEIN FUNCTION; REVIEW; SIALYLATION; STRUCTURE ANALYSIS; TISSUE SPECIFICITY; VIRAL TROPISM; VIRUS INFECTIVITY; VIRUS INTERFERENCE; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION;

EID: 84988353314     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2016.00358     Document Type: Review

References (160)

1. Aguzzi, A. (2014). Neurodegeneration: alzheimer's disease under strain. Nature 512, 32-34. doi: 10.1038/512032a.
2. Aguzzi, A., Heppner, F. L., Heikenwalder, M., Prinz, M., Mertz, K., Seeger, H., et al. (2003). Immune system and peripheral nerves in propagation of prions to CNS. Br. Med. Bull. 66, 141-159. doi: 10.1093/bmb/66.1.141.
3. Aguzzi, A., Nuvolone, M., and Zhu, C. (2013). The immunology of prion diseases. Nat. Rev. Immunol. 13, 888-902. doi: 10.1038/nri3553.
4. Amenitsch, H., Benetti, F., Ramos, A., Legname, G., and Requena, J. R. (2013). SAXS structural study of PrP(Sc) reveals ~11 nm diameter of basic double intertwined fibers. Prion 7, 496-500. doi: 10.4161/pri.27190.
5. Aminoff, D., Bruegge, W. F., Bell, W. C., Sarpolis, K., and Williams, R. (1977). Role of sialic acid in survival of erythrocytes in the circulation: interaction of neuraminidase-treated and untreated erythrocytes with spleen and liver at the cellular level. Proc. Acad. Natl. Sci. U.S.A. 74, 1521-1524. doi: 10.1073/pnas.74.4.1521.
6. Andréoletti, O., Berthon, P., Marc, D., Sarradin, P., Grosclaude, J., van Keulen, L., et al. (2000). Early accumulation of PrP(Sc) in gut-associated lymphoid and nervous tissues of susceptible sheep from a Romanov flock with natural scrapie. J. Gen. Virol. 81, 3115-3126. doi: 10.1099/0022-1317-81-12-3115.
7. Asante, E. A., Linehan, J. M., Desbruslais, M., Joiner, S., Gowland, I., Wood, A. L., et al. (2002). BSE prions propagate as either variant CJD-like or sporadic CJD-like prion stains in transgenic mice expressing human prion protein. EMBO J. 21, 6358-6366. doi: 10.1093/emboj/cdf653.
8. Audry, M., Jeanneau, C., Imberty, A., Harduin-Lepers, A., Delannoy, P., and Breton, C. (2011). Current trend in the structure-activity relationships of sialylatransferases. Glycobiology 21, 716-726. doi: 10.1093/glycob/cwq189.
9. Ayers, J. I., Schutt, C. R., Shikiya, R. A., Aguzzi, A., Kincaid, A. E., and Bartz, J. C. (2011). The strain-encoded relationship between PrP replication, stability and processing in neurons is predictive of the incubation period of disease. PLoS Pathog. 7:e1001317. doi: 10.1371/journal.ppat.1001317.
10. Bartz, J. C., Kramer, M. L., Sheehan, M. H., Hutter, J. A., Ayers, J. I., Bessen, R. A., et al. (2007). Prion interference is due to a reduction in strain-specific PrPSc levels. J. Virol. 81, 689-697. doi: 10.1128/JVI.01751-06.
11. Baskakov, I. V., Legname, G., Prusiner, S. B., and Cohen, F. E. (2001). Folding of prion protein to its native à-helical conformation is under kinetic control. J. Biol. Chem. 276, 19687-19690. doi: 10.1074/jbc. C100180200.
12. Bate, C., Nolan, W., McHale-Owen, H., and Williams, A. (2016a). Sialic acid within the glycosylphosphatidylinositol anchor targets the cellular prion protein to synapses. J. Biol. Chem. doi: 10.1074/jbc. M115.672394. [Epub ahead of print].
13. Bate, C., Nolan, W., and Williams, A. (2016b). Sialic acid on the glycosylphosphatidylinositol anchor regulates PrP-mediated cell signaling and prion formation. J. Biol. Chem. 291, 160-170. doi: 10.1074/jbc. M115.672394.
14. Bate, C., and Williams, A. (2012a). Clustring of sialylated glycocylphosphatidylinositol anchors mediated PrP-induced activation of cytoplasmic phospholipase A2 and synapse damage. Prion 6, 350-353. doi: 10.4161/pri.21751.
15. Bate, C., and Williams, A. (2012b). Neurodegeneration induced by clustering of sialylated glycosylphosphatidylinositols of prion proteins. J. Biol. Chem. 287, 7935-7944. doi: 10.1074/jbc. M111.275743.
16. Béringue, V., Herzog, L., Jaumain, E., Reine, F., Sibille, P., Le Dur, A., et al. (2012). Facilitated cross-species transmission of prions in extraneural tissue. Science 335, 472-475. doi: 10.1126/science.1215659.
17. Bishop, M. T., Diack, A. B., Ritchie, D. L., Ironside, J. W., Will, R. G., and Manson, J. C. (2013). Prion infectivity in the spleen of a PRNP heterozygous individual with subclinical variant Creutzfeldt-Jakob disease. Brain 136, 1139-1145. doi: 10.1093/brain/awt032.
18. Bishop, M. T., Hart, P., Aitchison, L., Baybutt, H. N., Plinston, C., Thomson, V., et al. (2006). Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurol. 5, 393-398. doi: 10.1016/S1474-4422(06)70413-6.
19. Bolton, D. C., Meyer, R. K., and Prusiner, S. B. (1985). Scrapie PrP 27-30 is a sialoglycoprotein. J. Virol. 53, 596-606.
20. Braak, H., and Braak, E. (1991). Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. 82, 239-259. doi: 10.1007/BF00308809.
21. Bradford, B. M., Crocker, P. R., and Mabbott, N. A. (2014). Peripheral prion disease pathogenesis is unaltered in the absence of sialoadhesin (Siglec-1/CD169). Immunology 143, 120-129. doi: 10.1111/imm.12294.
22. Brown, G. C., and Neher, J. J. (2014). Microglial phagocytosis of live neurons. Nat. Rev. Neurosci. 15, 209-216. doi: 10.1038/nrn3710.
23. Brown, K. L., Stewart, K., Ritchie, D. L., Mabbott, N. A., Williams, A., Fraser, H., et al. (1999). Scrapie replication in lyphoid tissues depends on prion protein-expressing follicular dendritic cells. Nat. Med. 5, 1308-1312. doi: 10.1038/15264.
24. Brown, P., and Gajdusek, D. C. (1991). The human spongiform encephalopathies: kuru, Creutzfeldt-Jakob disease, and the Gerstmann-Sträussler-Scheinker syndrome. Curr. Top. Microbiol. Immunol. 172, 1-20. doi: 10.1007/978-3-642-76540-7_1.
25. Cabral, M. G., Piteira, A. R., Silva, Z., Ligeiro, D., Brossmer, R., and Videira, P. A. (2010). Human dendritic cells contain cell surface sialyltransferase activity. Immunol. Lett. 131, 89-96. doi: 10.1016/j.imlet.2010.02.009.
26. Calero, O., Bullido, M. J., Clarimón, J., Frank-García, A., Martínez-Martín, P., Lleó, A., et al. (2012). A common BACE1 polymorphism is a risk factor for sporadic Creutzfeldt-Jakob disease. PLoS ONE 7:0043926. doi: 10.1371/journal.pone.0043926.
27. Cassard, H., Torres, J. M., Lacroux, C., Douet, J. Y., Benestad, S. L., Lantier, F., et al. (2014). Evidence for zoonotic potential of ovine scrapie prions. Nat. Commun. 5, 5821. doi: 10.1038/ncomms6821.
28. Castro-Seoane, R., Hummerich, H., Sweeting, T., Tattum, M. H., Linehan, J. M., Fernandez de Marco, M., et al. (2012). Plasmacytoid dendritic cells sequester high prion titres at early stages of prion infection. PLoS Pathog. 8:e1002538. doi: 10.1371/journal.ppat.1002538.
29. Chen, S., Mangé, A., Dong, L., Lehmann, S., and Schachner, M. (2003). Prion protein as trans-ineracting partner for neurons is involved in neurite outgrowth and neuronal survival. Mol. Cell. Neurosci. 22, 227-233. doi: 10.1016/S1044-7431(02)00014-3.
30. Cobb, N. J., Sönnichsen, F. D., McHaourab, H., Surewicz, W.,and K. (2007). Molecular architecture of human prion protein amyloid: a parallel, in-register b-structure. Proc. Acad. Natl. Sci. U.S.A. 104, 18946-18951. doi: 10.1073/pnas.0706522104.
31. Cohen, F. E., and Prusiner, S. B. (1998). Pathologic conformations of prion proteins. Annu. Rev. Biochem. 67, 793-819. doi: 10.1146/annurev.biochem.67.1.793.
32. Colby, D. W., Giles, K., Legname, G., Wille, H., Baskakov, I. V., DeArmond, S. J., et al. (2009). Design and construction of diverse mammalian prion strains. Proc. Acad. Natl. Sci. U.S.A. 106, 20417-20422. doi: 10.1073/pnas.0910350106.
33. Collinge, J., Palmer, M. S., Sidle, K. C., Hill, A. F., Gowland, I., Meads, J., et al. (1995). Unaltered susceptibility to BSE in transgenic mice expressing human prion protein. Nature 378, 779-783. doi: 10.1038/378779a0.
34. Collinge, J., Sidle, K. C. L., Meads, J., Ironside, J., and Hill, A. F. (1996). Molecular analysis of prion strain variation and the aetiology of "new variant" CJD. Nature 383, 685-690. doi: 10.1038/383685a0.
35. Collins, B. E., Blixt, O., DeSieno, A. R., Bovin, N., Marth, J. D., and Paulson, J. C. (2004). Masking of CD22 by cis ligands does not prevent redistribution of CD22 to sites of cell contact. Proc. Acad. Natl. Sci. U.S.A. 101, 6104-6109. doi: 10.1073/pnas.0400851101.
36. DeArmond, S. J., Qiu, Y., Sànchez, H., Spilman, P. R., Ninchak-Casey, A., Alonso, D., et al. (1999). PrPC glycoform heterogeneity as a function of brain region: implications for selective targeting of neurons by prion strains. J. Neuropathol. Exp. Neurol. 58, 1000-1009.
37. Dickinson, A. G., Fraser, H., Meikle, V. M. H., and Outram, G. W. (1972). Competition between different scrapie agents in mice. Nat. New Biol. 237, 244-245. doi: 10.1038/newbio237244a0.
38. Endo, T., Groth, D., Prusiner, S. B., and Kobata, A. (1989). Diversity of oligosaccharide structures linked to asparagines of the scrapie prion protein. Biochemistry 28, 8380-8388. doi: 10.1021/bi00447a017.
39. Fukuda, M., Hiraoka, N., and Yeh, J. C. (1999). C-Type lectins and sialyl lewis X Oligosaccharides versatile roles in cell-cell interaction. J. Cell Biol. 147, 467-470. doi: 10.1083/jcb.147.3.467.
40. Gonzalez-Montalban, N., Makarava, N., Savtchenko, R., and Baskakov, I. V. (2011). Relationship between conformational stability and amplification efficiency of prions. Biochemistry 50, 7933-7940. doi: 10.1021/bi200950v.
41. Govaerts, C., Wille, H., Prusiner, S. B., and Cohen, F. E. (2004). Evidance for assembly of prions with left-handed b-helices into trimers. Proc. Acad. Natl. Sci. U.S.A. 101, 8342-8347. doi: 10.1073/pnas.0402254101.
42. Gross, H. J., Merling, A., Moldenhauer, G., and Schwartz-Albiez, R. (1996). Ecto-sialyltransferase of human B lymphocytes reconstitutes differentiation markers in the presence of exogenous CMP-N-acetyl neuraminic acid. Blood 87, 5113-5126.
43. Groveman, B. R., Dolan, M. A., Taubner, L. M., Kraus, A., Wickner, R. B., and Caughey, B. (2014). Parallel in-register intermolecular β-sheet architectures for prion-seeded prion protein (PrP) amyloids. J. Biol. Chem. 289, 24129-24142. doi: 10.1074/jbc. M114.578344.
44. Guillerme-Bosselut, F., Forestier, L., Jayat-Vignoles, C., Vilotte, J. L., Popa, I., Portoukalian, J., et al. (2009). Glycosylation-related gene expression profiling in the brain and spleen of scrapie-affected mouse. Glycobiology 19, 879-889. doi: 10.1093/glycob/cwp062.
45. Halliez, S., Reine, F., Herzog, L., Juamain, E., Haïk, S., Rezaei, H., et al. (2014). Accelerated, spleen-based titration of variant Creutzfeldt-Jakob disease infectivity in transgenic mice expressing human prion protein with sensitivity comparable to that of survival time bioassay. J. Virol. 88, 8678-8686. doi: 10.1128/JVI.01118-14.
46. Harduin-Lepers, A., Vallejo-Ruiz, V., Krzewinski-Recchi, M. A., Samyn-Petit, B., Julien, S., and Delannoy, P. (2001). The human sialyltransferase family. Biochimie 83, 727-737. doi: 10.1016/S0300-9084(01)01301-3.
47. Hill, A. F., Butterworth, R. J., Joiner, S., Jackson, G., Rossor, M. N., Thomas, D. J., et al. (1999). Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 353, 183-189. doi: 10.1016/S0140-6736(98)12075-5.
48. Hilton, D. A., Fathers, E., Edwards, P., Ironside, J. W., and Zajicek, J. (1998). Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet 352, 703-704. doi: 10.1016/S0140-6736(98)24035-9.
49. Hilton, D. A., Ghani, A. C., Conyers, L., Edwards, P., McCardle, L., Ritchie, D., et al. (2004). Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J. Pathol. 203, 733-739. doi: 10.1002/path.1580.
50. Huang, F. P., Farquhar, C. F., Mabbott, N. A., Bruce, M. E., and MacPherson, G. G. (2002). Migrating intestinal dendritic cells transport PrPSc from the gut. J. Gen. Virol. 83, 267-271. doi: 10.1099/0022-1317-83-1-267.
51. Jansen, A. J. G., Josefsson, E. C., Rumjantseva, V., Liu, Q. P., Falet, H., Bergmeier, W., et al. (2012). Desialylation accelerates platelet clearance after refrigeration and initiates GPIba metalloproteinase-mediated cleavage in mice. Blood 119, 1263-1273. doi: 10.1182/blood-2011-05-355628.
52. Jucker, M., and Walker, L. C. (2013). Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 501, 45-51. doi: 10.1038/nature12481.
53. Katorcha, E., Klimova, N., Makarava, N., Savtchenko, R., Pan, X., Annunziata, I., et al. (2015a). Knocking out of cellular neuraminidases Neu1, Neu3 or Neu4 does not affect sialylation status of the prion protein. PLoS ONE 10:e0143218. doi: 10.1371/journal.pone.0143218.
54. Katorcha, E., Makarava, N., Savtchenko, R., and Baskakov, I. V. (2015b). Sialylation of the prion protein glycans controls prion replication rate and glycoform ratio. Sci. Rep. 5:16912. doi: 10.1038/srep16912.
55. Katorcha, E., Makarava, N., Savtchenko, R., D'Azzo, A., and Baskakov, I. V. (2014). Sialylation of prion protein controls the rate of prion amplification, the cross-species barrier, the ratio of PrPSc glycoform and prion infectivity. PLoS Pathog. 10:e1004366. doi: 10.1371/journal.ppat.1004366.
56. Katorcha, E., Srivastava, S., Klimova, N., and Baskakov, I. V. (2016). Sialylation of GPI anchors of mammalian prions is regulated in a host-, tissue-and cell-specific manner. J. Biol. Chem. doi: 10.1074/jbc. M116.732040. [Epub ahead of print].
57. Kaufmann, M., Blaser, C., Takashima, S., Schwartz-Albiez, R., Tsuji, S., and Pircher, H. (1999). Identification of an alpha2,6-sialyltransferase induced early after lymphocyte activation. Int. Immunol. 11, 731-738. doi: 10.1093/intimm/11.5.731.
58. Kimberlin, R. H., and Walker, C. A. (1985). Competition between strains of scrapie depends on the blocking agent being infectious. Intervirology 23, 74-81. doi: 10.1159/000149588.
59. Kovacs, G. G., Makarava, N., Savtchenko, R., and Baskakov, I. V. (2013). Atypical and classical forms of the disease-associated state of the prion protein exhibit distinct neuronal tropism, deposition patterns, and lesion profiles. Am. J. Pathol. 183, 1539-1547. doi: 10.1016/j.ajpath.2013.07.024.
60. Kujala, P., Raymond, C. R., Romeijn, M., Godsave, S. F., van Kasteren, S. I., Wille, H., et al. (2011). Prion Uptake in the Gut: identification of the first uptake and replication sites. PLoS Pathog. 7:e1002449. doi: 10.1371/journal.ppat.1002449.
61. Lawson, V. A., Collins, S. J., Masters, C. L., and Hill, A. F. (2005). Prion protein glycosylation. J. Neurochem. 93, 793-801. doi: 10.1111/j.1471-4159.2005.03104.x.
62. Lee, Y. J., and Baskakov, I. V. (2010). Treatment with normal prion protein delays differentiation and helps to maintain proliferating activity in human embryonic stem cells. J. Neurochem. 114, 362-373. doi: 10.1111/j.1471-4159.2010.06601.x.
63. Lee, Y. J., and Baskakov, I. V. (2013). The cellular form of the prion protein is involved in controlling cell cycle dynamics, self-renewal, and the fate of human embryonic stem cell differentiation. J. Neurochem. 124, 310-322. doi: 10.1111/j.1471-4159.2012.07913.x.
64. Lee, Y. J., and Baskakov, I. V. (2014). The cellular form of the prion protein guides the differentiation of human embryonic stem cells into neuron-, oligodendrocyte-, and astrocyte-committed lineages. Prion 8, 266-275. doi: 10.4161/pri.32079.
65. Legname, G., Baskakov, I. V., Nguyen, H. O. B., Riesner, D., Cohen, F. E., DeArmond, S. J., et al. (2004). Synthetic mammalian prions. Science 305, 673-676. doi: 10.1126/science.1100195.
66. Li, C., Wong, P., Pan, T., Xiao, F., Yin, S., Chang, B., et al. (2007). Normal cellular prion protein is a ligand of selectins: binding requires Lex but is inhibited by sLex. Biochem. J. 406, 333-341. doi: 10.1042/BJ20061857.
67. Lima, F. R., Arantes, C. P., Muras, A. G., Nomizo, R., Brentani, R. R., and Martins, V. R. (2007). Cellular prion protein expression in astrocytes modulates neuronal survival and differentiation. J. Neurochem. 103, 2164-2176. doi: 10.1111/j.1471-4159.2007.04904.x.
68. Linnartz, B., Kopatz, J., Tenner, A. J., and Neumann, H. (2012). Sialic acid on the neuronal glycocalyx prevents complement C1 binding and complement receptor-3-mediated removal by microglia. J. Neurosci. 32, 946-952. doi: 10.1523/JNEUROSCI.3830-11.2012.
69. Linnartz-Gerlach, B., Schuy, C., Shahraz, A., Tenner, A. J., and Neumann, H. (2016). Sialylation of neurites inhibits complement-mediated macrophage removal in a human macrophage-neuron Co-Culture System. Glia 64, 35-47. doi: 10.1002/glia.22901.
70. Makarava, N., Kovacs, G. G., Savtchenko, R., Alexeeva, I., Budka, H., Rohwer, R. G., et al. (2011). Genesis of mammalian prions: from non-infectious amyloid fibrils to a transmissible prion disease. PLoS Pathog. 7:e1002419. doi: 10.1371/journal.ppat.1002419.
71. Makarava, N., Kovacs, G. G., Savtchenko, R., Alexeeva, I., Ostapchenko, V. G., Budka, H., et al. (2012a). A new mechanism for transmissible prion diseases. J. Neurosci. 32, 7345-7355. doi: 10.1523/JNEUROSCI.6351-11.2012.
72. Makarava, N., Savtchenko, R., Alexeeva, I., Rohwer, R. G., and Baskakov, I. V. (2012b). Fast and ultrasensitive method for quantitating prion infectivity titer. Nat. Commun. 3, 741. doi: 10.1038/ncomms1730.
73. Makarava, N., Savtchenko, R., Alexeeva, I., Rohwer, R. G., and Baskakov, I. V. (2016). New molecular insight into mechanism of evolution of mammalian synthetic prions. Am. J. Pathol. 186, 1006-1014. doi: 10.1016/j.ajpath.2015.11.013.
74. Makarava, N., Savtchenko, R., and Baskakov, I. V. (2013). Selective amplification of classical and atypical prions using modified protein misfolding cyclic amplification J. Biol. Chem. 288, 33-41. doi: 10.1074/jbc. M112.419531.
75. Makarava, N., Savtchenko, R., and Baskakov, I. V. (2015). Two alternative pathways for generating transmissible prion disease de novo. Acta Neuropathol. Commun. 3:69. doi: 10.1186/s40478-015-0248-5.
76. Málaga-Trillo, E., Solis, G. P., Schrock, Y., Geiss, C., Luncz, L., Thomanetz, V., et al. (2009). Regulation of embryonic cell adhesion by the prion protein. PLoS Biol. 7:e1000055. doi: 10.1371/journal.pbio.1000055.
77. Martin, L. T., Marth, J. D., Varki, A., and Varki, N. M. (2002). Genetically altered mice with different sialyltransferase defficiencies show tissue-specific alterations in sialylation and sialic acid 9-O-acetilation. J. Biol. Chem. 277, 32930-32938. doi: 10.1074/jbc. M203362200.
78. McCulloch, L., Brown, K. L., Bradford, B. M., Hopkins, J., Bailey, M., Rajewsky, K., et al. (2011). Follicular dendritic cell-specific prion protein (PrP) expression alone is sufficient to sustain prion infection in the spleen. PLoS Pathog. 7:e1002402. doi: 10.1371/journal.ppat.1002402.
79. Mehrabian, M., Brethour, D., Wang, H., Xi, Z., Rogaeva, E., and Schmitt-Ulms, G. (2015). The prion protein controls polysialylation of neural cell adhesion molecule 1 during cellular morphogenesis. PLoS ONE 10:e0133741. doi: 10.1371/journal.pone.0133741.
80. Michel, B., Meyerett-Reid, C., Johnson, T., Ferguson, A., Wyckoff, C., Pulford, B., et al. (2012). Incunabular imminological events in prion trafficing. Sci. Rep. 2:440. doi: 10.1038/srep00440.
81. Miller, M. W., and Williams, E. S. (2004). Chronic wasting disease of cervids. Curr. Top. Microbiol. Immunol. 284, 193-214. doi: 10.1007/978-3-662-08441-0_8.
82. Miyagi, T., and Yamaguchi, K. (2012). Mammalian sialidases: physiological and pathological roles in cellular functions. Glycobiology 22, 880-896. doi: 10.1093/glycob/cws057.
83. Monnet, C., Marthiens, V., Enslen, H., Frobert, Y., Sobel, A., and Mège, R. M. (2003). Heterogeneity and regulation of cellular prion protein glycoforms in neuronal cell lines. Eur. J. Neurosci. 18, 542-548. doi: 10.1046/j.1460-9568.2003.02777.x.
84. Monti, E., Bonten, E., D'Azzo, A., Bresciani, R., Venerando, B., Borsani, G., et al. (2010). Sialidases in vertebrates: a family of enzymes tailored for several cell functions. Adv. Carbohydr. Chem. Biochem. 64, 403-479. doi: 10.1016/S0065-2318(10)64007-3.
85. Montrasio, F., Frigg, R., Glatzel, M., Klein, M. A., Mackay, F., Aguzzi, A., et al. (2000). Impaired prion replication in spleens of mice lacking functional follicular dendritic cells. Science 288, 1257-1259. doi: 10.1126/science.288.5469.1257.
86. Morales, R., Bravo-Alegria, J., Duran-Aniotz, C., and Soto, C. (2015). Titration of biologically active amyloid-β seeds in a transgenic mouse model of Alzheimer's disease. Sci. Rep. 5:9343. doi: 10.1038/srep09349.
87. Morales, R., Hu, P. P., Duran-Aniotz, C., Moda, F., Diaz-Espinoza, R., Chen, B., et al. (2016). Strain-dependent profile of misfolded prion protein aggregates. Sci. Rep. 6:20526. doi: 10.1038/srep20526.
88. Mouillet-Richard, S., Laurendeau, I., Vidaud, M., Kellermann, O., and Laplamche, J. L. (1999). Prion protein and neuronal differentiation: quantitative analysis of prnp gene expression in a murine inducible neuroectodermal progenitor. Microbes Infect. 1, 969-976. doi: 10.1016/S1286-4579(99)80514-0.
89. Nasirikenari, M., Veillon, L., Collins, C. C., Azadi, P., and Lau, J. T. (2014). Remodeling of marrow hematopoietic stem and progenitor cells by non-self ST6Gal-1 sialyltransferase. J. Biol. Chem. 289, 7178-7189. doi: 10.1074/jbc. M113.508457.
90. Ng, P. S., Böhm, R., Hartley-Tassell, L. E., Steen, J. A., Wang, H., Lukowski, S. W., et al. (2014). Ferrets exclusively synthesize Neu5Ac and express naturally humanized influenza A virus receptors. Nat. Commun. 5, 5750. doi: 10.1038/ncomms6750.
91. Nishina, K., Deleault, N. R., Mahal, S., Baskakov, I., Luhrs, T., Riek, R., et al. (2006). The stoichiometry of host PrPC glycoforms modulates the efficiency of PrPSc formation in vitro. Biochemistry 45, 14129-14139. doi: 10.1021/bi061526k.
92. Novitskaya, V., Makarava, N., Sylvester, I., Bronstein, I. B., and Baskakov, I. V. (2007). Amyloid fibrils of mammalian prion protein induce axonal degeneration in NTERA2-derived terminally differentiated neurons. J. Neurochem. 102, 398-407. doi: 10.1111/j.1471-4159.2007.04537.x.
93. Ostapchenko, V. G., Sawaya, M. R., Makarava, N., Savtchenko, R., Nilsson, K. P., Eisenberg, D., et al. (2010). Two amyloid states of the prion protein display significantly different folding patterns. J. Mol. Biol. 400, 908-921. doi: 10.1016/j.jmb.2010.05.051.
94. Panigaj, M., Glier, H., Wildova, M., and Holada, K. (2011). Expression of prion protein in mouse erythroid progenitors and differentiating murine erythroleukemia cells. PLoS ONE 6:e24599. doi: 10.1371/journal.pone.0024599.
95. Pan, T., Li, R., Kang, S. C., Pastore, M., Wong, B. S., Ironside, J., et al. (2005). Biochemical fingerprints of prion diseases: scrapie prion protein in human prion diseases that share prion genotype and type. J. Neurochem. 92, 132-142. doi: 10.1111/j.1471-4159.2004.02859.x.
96. Peden, A. H., Head, M. W., Ritchie, D. L., Bell, J. E., and Ironside, J. W. (2004). Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364, 527-529. doi: 10.1016/S0140-6736(04)16811-6.
97. Peden, A., McCardle, L., Head, M. W., Love, S., Ward, H. J., Cousens, S. N., et al. (2010). Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia. Haemophilia 16, 296-304. doi: 10.1111/j.1365-2516.2009.02181.x.
98. Peretz, D., Scott, M. R., Groth, D., Williamson, R. A., Burton, D. R., Cohen, F. E., et al. (2001). Strain-specified relative conformational stability of the scrapie prion protein. Protein Sci. 10, 854-863. doi: 10.1110/ps.39201.
99. Prusiner, S. B. (1982). Novel proteinaceous infectious particles cause scrapie. Science 216, 136-144. doi: 10.1126/science.6801762.
100. Prusiner, S. B. (1998). Prions. Proc. Natl. Acad. Sci. U.S.A. 95, 13363-13383. doi: 10.1073/pnas.95.23.13363.
101. Pshezhetsky, A. V., and Ashmarina, L. I. (2013). Desialylation of Surface Receptors as a New Dimension in Cell Signaling. Biochemistry (Mosc) 78, 736-745. doi: 10.1134/S0006297913070067.
102. Rabinovich, G. A., and Croci, D. O. (2012). Regulatori circuits mediated by lectin-glycan interaction in autoimmunity and cancer. Immunity 36, 322-335. doi: 10.1016/j.immuni.2012.03.004.
103. Requena, J. R., and Wille, H. (2014). The Structure of the infectious prion protein: experimental data and molecular models. Prion 8, 60-66. doi: 10.4161/pri.28368.
104. Rifat, S., Kang, T. J., Mann, D., Zhang, L., Puche, A. C., Stamatos, N. M., et al. (2008). Expression of sialyltransferase activity on intact human neutrophils. J. Leukoc. Biol. 84, 1075-1081. doi: 10.1189/jlb.0706462.
105. Rudd, P. M., Endo, T., Colominas, C., Groth, D., Wheeler, S. F., Harvey, D. J., et al. (1999). Glycosylation differences between the normal and pathogenic prion protein isoforms. Proc. Natl. Acad. Sci. U.S.A. 96, 13044-13049. doi: 10.1073/pnas.96.23.13044.
106. Samraj, A. N., Pearce, O. M. T., Läubli, H., Crittenden, A. N., Bergfeld, A. K., Banda, K., et al. (2015). A red meat-derived glycan promotes inflammation and cancer progression. Proc. Acad. Natl. Sci. U.S.A. 112, 542-547. doi: 10.1073/pnas.1417508112.
107. Santos, T. G., Silva, I. R., Costa-Silva, B., Lepigue, A. P., Martins, V. R., and Lopes, M. H. (2011). Enhanced neural progenitor/stem cells self-renewal via the interaction of stress-inducible protein 1 with the prion protein. Stem Cells 29, 1126-1136. doi: 10.1002/stem.664.
108. Santuccione, A., Syntyk, V., Leshchyns'ka, I., and Schachner, M. (2005). Prion protein recruits its neuronal receptor NCAM to lipid rafts to activate p59fyn and to enhance neurite outgrowth. J. Cell Biol. 169 341-354. doi: 10.1083/jcb.200409127.
109. Savill, J., Dransfield, I., Gregory, C., and Haslett, C. (2002). A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2, 965-975. doi: 10.1038/nri957.
110. Schauer, R., Srinivasan, G. V., Wipfer, D., Kniep, B., and Schwartz-Albiez, R. (2011). "O-Acetylated sialic acids and their role in immune defence," in The Molecular Immunology of Complex Carbohydrates-3, ed A. M. Wu (New York, NY; Dordrecht; Heidelberg; London: Springer Science), 525-548.
111. Schmitt-Ulms, G., Legname, G., Baldwin, M. A., Ball, H. L., Bradon, N., Bosque, P. J., et al. (2001). Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein. J. Mol. Biol. 314, 1209-1225. doi: 10.1006/jmbi.2000.5183.
112. Schmitz, M., Lullmann, K., Zafar, S., Ebert, E., Wohlhage, M., Oikonomou, P., et al. (2014). Association of prion protein genotype and scrapie prion protein type with cellular prion protein charge isoform profiles in cerebrospinal fluid of humans with sporadic or familial prion diseases. Neurobiol. Aging 35, 1177-1188. doi: 10.1016/j.neurobiolaging.2013.11.010.
113. Schutt, C. R., and Bartz, J. C. (2008). Prion interference with multiple prion isolates. Prion 2, 61-63. doi: 10.4161/pri.2.2.6806.
114. Schwartz-Albiez, R., Merling, A., Martin, S., Haas, R., and Gross, H. J. (2004). Cell surface sialylation and ecto-sialyltransferase activity of human CD34 progenitors from peripheral blood and bone marrow. Glycoconj. J. 21, 451-459. doi: 10.1007/s10719-004-5535-5.
115. Shikiya, R. A., Ayers, J. I., Schutt, C. R., Kincaid, A. E., and Bartz, J. C. (2010). Coinfecting prion strains compete for a limiting cellular resource. J. Virol. 84, 5706-5714. doi: 10.1128/JVI.00243-10.
116. Sigurdson, C. J., Williams, E. S., Miller, M. W., Spraker, T. R., O'Rourke, K. I., and Hoover, E. A. (1999). Oral transmission and early lymphoid tropism of chronic wasting disease PrPres in mule deer fawns (Odocoileus hemionus). J. Gen. Virol. 80, 2757-2764. doi: 10.1099/0022-1317-80-10-2757.
117. Solforosi, L., Criado, J. R., McGavern, D. B., Wirz, S., Sánchez-Alavez, M., Sugama, S., et al. (2004). Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science 303, 1514-1516. doi: 10.1126/science.1094273.
118. Solomon, I. H., Khatri, N., Biasini, E., Massignan, T., Huettner, J. E., and Harris, D. A. (2011). An N-terminal polybasic domain and cell surface localization are required for mutant prion protein toxicity. J. Biol. Chem. 286, 14724-14736. doi: 10.1074/jbc. M110.214973.
119. Somerville, R. A. (1999). Host and transmissible spongiform encephalopathy agent strain control glycosylation of PrP. J. Gen. Virol. 80, 1865-1872. doi: 10.1099/0022-1317-80-7-1865.
120. Sonati, T., Reimann, R. R., Falsig, J., Baral, P. K., O'Connor, T., Hornemann, S., et al. (2012). The toxicity of antiprion antibodies is mediated by the flexible tail of the prion protein. Nature 501, 102-106. doi: 10.1038/nature12402.
121. Soto, C., Estrada, L., and Castilla, J. (2006). Amyloids, prions and the inherent infectious nature of misfolded protein aggregates. Trends Biochem. Sci. 31, 150-155. doi: 10.1016/j.tibs.2006.01.002.
122. Spassov, S., Beekes, M., and Naumann, D. (2006). Structural differences between TSEs strains investigated by FT-IR spectroscopy. Biochim. Biophys. Acta 1760, 1138-1149. doi: 10.1016/j.bbagen.2006.02.018.
123. Srivastava, S., Makarava, N., Katorcha, E., Savtchenko, R., Brossmer, R., and Baskakov, I. V. (2015). Post-conversion sialylation of prions in lymphoid tissues. Proc. Acad. Natl. Sci. U.S.A. 112, E6654-E6662. doi: 10.1073/pnas.1517993112.
124. Stahl, N., Baldwin, M. A., Hecker, R., Pan, K. M., Burlingame, A. L., and Prusiner, S. B. (1992). Glycosylinositol phospholipid anchors of the scrapie and cellular prion proteins contain sialic acid. Biochemistry 31, 5043-5053. doi: 10.1021/bi00136a600.
125. Stahl, N., Baldwin, M. A., Teplow, D. B., Hood, L., Gibson, B. W., Burlingame, A. L., et al. (1993). Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry 32, 1991-2002. doi: 10.1021/bi00059a016.
126. Stahl, N., Borchelt, D. R., Hsiao, K., and Prusiner, S. B. (1987). Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 51, 229-240. doi: 10.1016/0092-8674(87)90150-4.
127. Steele, A. D., Emsley, J. G., Ozdinler, P. H., Lindquist, S., and Macklis, J. D. (2006). Prion protein (PrPC) positively regulates neural precursor proliferation during developmental and adult mammalian neurogenesis. Proc. Acad. Natl. Sci. U.S.A. 103, 3416-3421. doi: 10.1073/pnas.0511290103.
128. Stimson, E., Hope, J., Chong, A., and Burlingame, A. L. (1999). Site-specific characterization of the N-linked glycans of murine prion protein by high-performance liquid chromatography/electrospray mass spectrometry and exoglycosidase digestions. Biochemistry 38, 4885-4895. doi: 10.1021/bi982330q.
129. Stöhr, J., Condello, C., Watts, C. J., Bloch, L., Oehler, A., Nick, M., et al. (2014). Distinct synthetic Aβ prion strains producing different amyloid deposits in bigenic mice. Proc. Acad. Natl. Sci. U.S.A. 111, 10329-10334. doi: 10.1073/pnas.1408968111.
130. Stura, E. A., Muller, B. H., Bossus, M., Michel, S., Jolivet-Reynaud, C., and Ducancel, F. (2011). Crystal structure of human prostate-specific antigen in a sandwich antibody complex. J. Mol. Biol. 414, 530-544. doi: 10.1016/j.jmb.2011.10.007.
131. Sun, Y., Breydo, L., Makarava, N., Yang, Q., Bocharova, O. V., and Baskakov, I. V. (2007). Site-specific conformational studies of PrP amyloid fibrils revealed two cooperative folding domain within amyloid structure. J. Biol. Chem. 282, 9090-9097. doi: 10.1074/jbc. M608623200.
132. Sun, Y., Makarava, N., Lee, C. I., Laksanalamai, P., Robb, F. T., and Baskakov, I. V. (2008). Conformational stability of PrP amyloid firbils controls their smallest possible fragment size. J. Mol. Biol. 376, 1155-1167. doi: 10.1016/j.jmb.2007.12.053.
133. Svennerholm, L., Bostrom, K., and Jungbjer, B. (1997). Changes in weight and compositions of major mambrane components oh human brain during the span of adult human life of Swedes. Acta Neuropathol. 94, 345-352. doi: 10.1007/s004010050717.
134. Takakura, I., Muiyazawa, K., Kanaya, T., Itani, W., Watanabe, K., Ohwada, S., et al. (2011). Orally administered prion protein is incorporated by m cells and spreads into lymphoid tissues with macrophages in prion protein knockout mice. Am. J. Pathol. 179, 1301-1309. doi: 10.1016/j.ajpath.2011.05.058.
135. Takashima, S. (2008). Characterization of mouse sialylatransferase gene: their evolution and diversity. Biosci. Biotechnol. Biochem. 72, 1155-1167. doi: 10.1271/bbb.80025.
136. Takashima, S., Truji, S., and Tsujimoto, M. (2002). Characterization of the second type of human beta-galactoside alpha 2,6-sialyltransferase (ST6Gal II), which sialylates Galbeta 1,4GlcNAc structures on oligosaccharides preferentially. Genomic analysis of human sialyltransferase genes. J. Biol. Chem. 277, 45719-45728. doi: 10.1074/jbc. M206808200.
137. Takashima, S., Tsuji, S., and Tsujimoto, M. (2003). Comparison of the enzymatic properties of mouse beta-galactoside alpha2,6-sialyltransferases, ST6Gal I and II. J. Biochem. 134, 287-296. doi: 10.1093/jb/mvg142.
138. Tanaka, K., Siwu, E. R. O., Minami, K., Hasegawa, K., Nozaki, S., Kanayama, Y., et al. (2010). Noninvasive imaging of dendrimer-type N-glycan clusters: in vivo dynamics dependence on oligosaccharide structure. Angew. Chem. Int. Ed. Engl. 49, 8195-8200. doi: 10.1002/anie.201000892.
139. Thomzig, A., Spassov, S., Friedrich, M., Naumann, D., and Beekes, M. (2004). Discriminating scrapie and bovine spongiform encephalopathy isolates by infrared spectroscopy of pathological prion protein. J. Biol. Chem. 279, 33854. doi: 10.1074/jbc.m403730200.
140. Turk, E., Teplow, D. B., Hood, L. E., and Prusiner, S. B. (1988). Purification and properties of the cellular and scrapie hamster prion proteins. Eur. J. Biochem. 176, 21-30. doi: 10.1111/j.1432-1033.1988.tb14246.x.
141. Turnbaugh, J. A., Unterberger, U., Saá, P., Massignan, T., Fluharty, B. R., Bowman, F. P., et al. (2012). The N-terminal, polybasic region of PrP(C) dictates the efficiency of prion propagation by binding to PrP(Sc). J. Neurosci. 32, 8817-8830. doi: 10.1523/JNEUROSCI.1103-12.2012.
142. Tycko, R., Savtchenko, R., Ostapchenko, V. G., Makarava, N., and Baskakov, I. V. (2010). The a-helical C-terminal domain of full-length recombinant PrP converts to an in-register parallel á-sheet structure in PrP fibrils: evidence from solid state nuclear magnetic resonance. Biochemistry 49, 9488-9497. doi: 10.1021/bi1013134.
143. Ushijima, H., Perovic, S., Leuck, J., Rytik, P. G., Müller, W. E., and Schröder, H. C. (1999). Suppression of PrP(Sc)-and HIV-1 gp120 induced neuronal cell death by sulfated colominic acid. J. Neurovirol. 5, 289-299. doi: 10.3109/13550289909015815.
144. Varki, A. (1999). "Sialic acids," in Essentials of Glycobiology, eds A. Varki, R. Cummings, J. Esko, H. Freeze, G. Hart, and J. Marth (Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press), 195-210.
145. Varki, A. (2008). Sialic acids in human health and disease. Trends Mol. Med. 14, 351-360. doi: 10.1016/j.molmed.2008.06.002.
146. Varki, A. (2010). Uniquely human evolution of sialic acid genetics and biology. Proc. Acad. Natl. Sci. U.S.A. 107, 8939-8946. doi: 10.1073/pnas.0914634107.
147. Viegas, P., Chaverot, N., Enslen, H., Perrière, N., Couraud, P. O., and Cazaubon, S. (2006). Junctional expression of the prion protein PrPC by brain endothelial cells: a role in trans-andothelial migration of human monocytes. J. Cell Sci. 119, 4634-4643. doi: 10.1242/jcs.03222.
148. Wadsworth, J. D., Asante, E. A., Desbruslais, M., Linehan, J. M., Joiner, S., Gowland, I., et al. (2004). Human prion protein with valine 129 prevents expression of variant CJD phenotype. Science 306, 1793-1796. doi: 10.1126/science.1103932.
149. Wadsworth, J. D., Joiner, S., Hill, A. F., Campbell, T. A., Desbruslais, M., Luthert, P. J., et al. (2001). Tissues distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunobloting assay. Lancet 358, 171-180. doi: 10.1016/S0140-6736(01)05403-4.
150. Walker, L. C., and Jucker, M. (2015). Neurodegenerative diseases: expanding the prion concept. Annu. Rev. Neurosci. 38, 87-103. doi: 10.1146/annurev-neuro-071714-033828.
151. Wang, S., Chen, X., Wei, A., Yu, X., Niang, B., and Zhang, J. (2015). a2,6-linked sialic acids on N-glycans modulate the adhesion of hepatocarcinoma cells to lymph nodes. Tumor Biol. 36, 885-892. doi: 10.1007/s13277-014-2638-x.
152. Wasmer, C., Lange, A., Van Melckebeke, H., Siemer, A. B., Riek, R., and Meier, B. H. (2008). Amyloid fibrils of the HET-s(218-289) prion form a beta solenoid with a triangular hydrophobic core. Science 319, 1523-1526. doi: 10.1126/science.1151839.
153. Watts, C. J., Condello, C., Stöhr, J., Oehler, A., Lee, J., DeArmond, S. J., et al. (2014). Serial propagation of distinct strains of Aβ prions from Alzheimer's disease patients. Proc. Acad. Natl. Sci. U.S.A. 111, 10323-10328. doi: 10.1073/pnas.1408900111.
154. Westergard, L., Turnbaugh, J. A., and Harris, D. A. (2011). A nine amino acid domain is essential for mutant prion protein toxicity. J. Neurosci. 31, 14005-14017. doi: 10.1523/JNEUROSCI.1243-11.2011.
155. Wille, H., Bian, W., McDonald, M., Kendall, A., Colby, D. W., Bloch, L., et al. (2009). Natural and synthetic prion structure from X-ray fiber diffraction. Proc. Acad. Natl. Sci. U.S.A. 106, 16990-16995. doi: 10.1073/pnas.0909006106.
156. Wille, H., Michelitsch, M. D., Guenebaut, V., Supattapone, S., Serban, A., Cohen, F. E., et al. (2002). Structural studies of the scrapie prion protein by electron crystallography. Proc. Acad. Natl. Sci. U.S.A. 99, 3563-3568. doi: 10.1073/pnas.052703499.
157. Wroe, S. J., Pal, S., Siddique, D., Hyare, H., Macfariane, R., Joiner, S., et al. (2006). Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Lancet 368, 2061-2067. doi: 10.1016/S0140-6736(06)69835-8.
158. Zanusso, G., Farinazzo, A., Prelli, F., Fiorini, F., Gelati, M., Ferrari, S., et al. (2004). Identification of distinct N-terminal truncated forms of prion protein in different Creutzfeldt-Jakob disease subtypes. J. Biol. Chem. 279, 38936-38942. doi: 10.1074/jbc. M405468200.
159. Zhang, C. C., Steele, A. D., Lindquist, S., and Lodish, H. F. (2006). Prion protein is expressed on long-term repopulating hematopoietic stem cells and is important for their self-renewal. Proc. Acad. Natl. Sci. U.S.A. 103, 21814-21819. doi: 10.1073/pnas.0510577103.
160. Zhang, Z., Sun, J., Hao, L., Liu, C., Ma, H., and Jia, L. (2013). Modification of glycosylation mediates the invasive properties of murine hepatocarcinoma cell lines to lymph nodes. PLoS ONE 8:e65218. doi: 10.1371/journal.pone.0065218.